Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia

Cost of Relapse in Schizophrenia

Peter J. Weiden, Mark Olfson · Schizophrenia Bulletin · 1995 · 675 citations · Full text

Pharmacy, Pharmacoeconomics, Psychiatry +17

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders

Thomas W. Haywood, Howard M. Kravitz, Linda S. Grossman et al. · American Journal of Psychiatry · 1995 · 495 citations

Medicine, Behavioral Sciences, Psychiatry +17

Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic

John M. Kane, Mariëlle Eerdekens, Jean‐Pierre Lindenmayer et al. · American Journal of Psychiatry · 2003 · 492 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

Haya Ascher‐Svanum, Douglas E. Faries, Baojin Zhu et al. · The Journal of Clinical Psychiatry · 2006 · 488 citations

Medicine, Pharmacotherapy, Psychiatry +17

Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part III

Michael L. Johnson, William H. Crown, Bradley C. Martin et al. · Value in Health · 2009 · 290 citations · Full text

Pharmacy, Biostatistics, Causal Inference +16